The particular Guardian view on gene therapy: money well spent | Editorial

T he or she NHS is to fund a very expensive treatment for an unusual but terrible childhood disorder that leaves babies ruined to life in a sterile bubble. This is  a  success for medical science but it should also provoke some strong and careful thought. The treatment in question, strimvelis, qualifies because the second most expensive drug ever put on the market (the just one more expensive was withdrawn due to lack of demand). A single dosage costs nearly £ 500, 000 plus VAT, and may only be administered in Milan, where the preparation is created. On  the...

Read More